microRNA 659 (miR-659)

microRNA 659 (miR-659) is a small, non-coding RNA molecule (microRNA) involved in the *post-transcriptional regulation* of gene expression by binding to specific sequences on target messenger RNAs (mRNAs), resulting in translational repression or mRNA degradation[7][4]. miR-659 has been functionally implicated in modulating the expression of several genes associated with the focal adhesion pathway and tumor metastasis, particularly in neuroblastoma, by indirectly regulating transcription factors and signaling molecules such as AKT3, BCL2, CYR61, and THSB2 through CNOT1[1][3]. It also binds to and regulates translation of the GRN gene, where a common genetic variant alters the efficiency of this suppression and contributes to risk for frontotemporal lobar degeneration[4]. miR-659 and its expression patterns have been considered as potential biomarkers for tumor classification and could serve as candidates for early cancer detection panels[2]. Like other microRNAs, its pleiotropic regulatory activities and lack of protein structure put it outside conventional target classes such as enzymes or receptors, instead positioning it as *a regulator of gene expression with clinical significance in oncogenesis and neurodegeneration*[7][4][1].

Other names

hsa-mir-659MIR659MIRN659mir-659hsa-miR-659miR-659-3p

Sequence-specific binding to complementary mRNA, leading to translational repression or mRNA degradation (typical for miRNAs)[7][4] Modulates translation of GRN depending on the allele (for example, increased inhibition of GRN translation via the T-allele of rs5848)[4]